A recall has been announced on all Digitek (generic digoxin) tablets because they may contain twice the approved level of digoxin. These "double-strength" tablets can cause Digitalis Toxicity, which can result in:
- Low blood pressure
- Cardiac instability
Digitek is manufactured by Actavis Totowa (formerly Amide Pharmaceutical, Inc.) and is a drug used to treat heart failure and abnormal heart rhythms. Mylan Pharmaceuticals distributes the drug under a "Bertek" label and by UDL Laboratories under a "UDL" label.
If you or someone you know has been taking digoxin (Digitek), please consult your physician immediately. Retailers who carry this drug should take it off the shelves and return it to the manufacturer immediately. Overdosing on this drug can be very dangerous and even lethal. Digoxin was even used in a series of murders in the 1980's and 1990's committed by a nurse who claimed to have ended his patients' "suffering."
It has been reported that manufacturing errors could have allowed twice the amount of active ingredients to be placed into tablets sold to consumers. Reports suggest that these double-strength tablets were sold for over a year.
The Digitek recall has been put into a Class I recall, which means that the product poses a substantial risk of serious injury or death. Individuals with renal failure or poor kidney function could suffer from the potentially fatal Digitalis Toxicity, which occurs with excess levels of the drug in the system. Pharmaceutical injury lawyers are reviewing Digitek cases now.
If you or a loved one has suffered adverse effects from the use of Digitek (digoxin), you may be entitled to compensation. We urge you to contact an experienced Digitek lawyer as soon as possible. There may be time limits in filing your claim.
Please contact PersonalInjury.com today to find an experienced digoxin attorney.